《Multiple Drug Resistance in Cancer》是一本圖書，作者是Clynes, Manfred
基本介紹
- 外文名：Multiple Drug Resistance in Cancer
- 作者：Clynes, Manfred
- 出版時間：1999年1月
- 頁數：355 頁
- ISBN：9780792352723
- 定價：326.57 美元
Multiple Drug Resistance in Cancer
相關詞條
- Drug Resistance in Cancer
Drug Resistance in Cancer 《Drug Resistance in Cancer》是一本圖書，作者是Goldie, J. H.; Goldie, James H.; Coldman, Andrew J.
- Drug Resistance in the Treatment of Cancer(Pinedo, Herbert M.; G...
《Drug Resistance in the Treatment of Cancer》是一本圖書，作者是Pinedo, Herbert M.; Giaccone, Giuseppe; Herbert M., Pinedo 內容簡介 The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cance...
- Drug Resistance in Cancer Therapy
Drug Resistance in Cancer Therapy 《Drug Resistance in Cancer Therapy》是一本圖書，作者是Ozols, Robert F.
- Drug Resistance in Cancer Cells
Drug Resistance in Cancer Cells 《Drug Resistance in Cancer Cells》是一本圖書，作者是Mehta, Kapil (EDT)
- Drug Resistance in the Treatment of Cancer(圖書)
Drug Resistance in the Treatment of Cancer 《Drug Resistance in the Treatment of Cancer》是一本圖書，作者是Pinedo, Herbert M.; Giaccone, Giuseppe; Sikora, Karol
- 梁麗嫻(澳門大學健康科學院教授)
4. Xie Y, Feng SL, He F, Yan PY, Yao XJ, Fan XX, Leung EL*, Zhou H*. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer. Pharmacological Research. 2022; 186: 106514. (IF=9.3)5. Wang J, ...
- 張曉艷(同濟大學教授)
7. Liu Xinyi, Li Zuofeng,Cai Qingqing，Zhang Xiaoyan*. Prediction of multiple drug resistance phenotype in cancer cell lines using gene expression profiles and phylogenetic trees. Chinese Sci Bull, 2010, 55: 3778−3786 （SCI 通訊作者）8.Xin Zhao, Zoufeng Li, Xiaoyan Zhang*. 2010. G6PD-...
- 李湘奇
Systemspharmacology in combination with proteomicsreveals underlying mechanisms of Xihuang pill against triple-negative breastcancer PTEN andSHIP: Impact on lymphatic metastasis in breast cancer NVP-CGM097,an HDM2 Inhibitor, Antagonizes ATP-binding Cassette Subfamily B Member1-Mediated Drug Resistance The...
- 黃河(浙江大學求是特聘教授,973首席科學家,主任醫師)
48. Hu K, Gu Y, Lou L, Liu L, Hu Y, Wang B, Luo Y, Shi J, Yu X, Huang H*. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.J Hematol Oncol. 2015 Jan 27;8(1):1.49. Gorin NC, Labopin M...
- 徐瑞華(中國醫學科學院學術諮詢委員會學部委員,腫瘤內科專家,中山大學...
截止2024年11月，徐瑞華以通訊或第一作者在國際期刊《新英格蘭醫學雜誌》（NEJM）、JAMA（2篇）、BMJ、Cell、Nature Med（5篇）、Nature Mater、Lancet Oncol（2篇）、Cancer Cell（3篇）、Ann Oncol(2篇)、JCO（2篇）、Lancet G&H（2篇）、JAMA Oncol（2篇） 等發表高水平成果論文200 余篇（30篇IF>30），...
- 馬永鋼
Reversal of Multidrug Resistance (MDR) by the Isoquinoline Alkaloid Glaucine. Ma Y, Wink M. Multiple Drug Resistance.2010. 203-211.The Beta-Carboline Alkaloid Harmine inhibits BCRP and Can Reverse Resistance to
- 高獻書
高獻書，男，主任醫師、教授，博士生導師，現北京大學第一醫院放療科主任，北京大學放射腫瘤學系主任，北京大學近距離治療中心副主任。專業特長為腫瘤的放射治療及綜合診治。1984年畢業於河北醫科大學獲學士學位，1995年於日本岡山大學獲博士學位。曾在日本岡山大學及美國MD Anderson Cancer Center從事放射腫瘤研究。致力於...
- 梁興傑(美國醫學與生物工程院院士,歐洲科學院院士,國家納米科學中心研 ...
截至2023年9月，梁興傑已在《自然·納米技術（Nature Nanotechnology）》 《自然·生物醫學工程（Nature Biomedical Engineering）》《科學進展（Science Advances）》《美國國家科學院院刊（PNAS）》《癌症研究（Cancer Research）》等國際學術期刊發表論文400餘篇，H -index＞98。發明專利 科研獎勵 人才培養 參編教材 梁興...
- 曾子晏
34. Huang WQ, Lin Q, Zhuang X, Cai LL, Ruan RS, LuZX, Tzeng CM. Structure, function, and pathogenesis of SHP2 in developmentaldisorders and tumorigenesis. Curr Cancer Drug Targets. 2014;14(6):567-88.doi:10.2174/1568009614666140717105001. PMID: 25039348.33. Lu CX, Qing Lin, Huang WQ...
- 陳維(中國藥科大學工學院博士生導師)
3.Z. Tu, H. Qiao, Y. Yan, G. Guday,W. Chen*, M. Adeli*, and R. Haag*, Directed Graphene-Based Nanoplatforms for Hyperthermia: Overcoming Multiple Drug Resistance,Angew. Chem.2018, 130, 11368 –11372(Angew. Chem. Int. Ed.2018, 57, 11198 –11202).4.D.C. Huang,Q. Zhang,Y. ...
- 顧兵(廣東省人民醫院檢驗科主任、學科帶頭人)
20. Xu N#, Wang L#, Li C, Ding C, Li C, Fan W, Cheng C, Gu B*. Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms. Transl Lung Cancer Res. 2020, 9(4):1554-1568. (JCR 2區, IF 6.498)21. Yang H#, Cai R#, Zhang Y#, Chen Y, Gu B*...
- 劉銀(同濟大學醫學院講師,肺科醫院主管檢驗師)
一、癌症表觀遺傳學和腫瘤靶向藥物耐藥 Cancer epigenetics and drug resistance of targeted therapy 二、腫瘤免疫 tumor immunity 海外經歷 2012-2014, Dana Farber Cancer Institute, Harvard University 2019-2021, Princess Margaret Cancer Research Center, University of Toronto 科研成果 主持項目：1. 同濟大學青年...
- 周文(中南大學基礎醫學院腫瘤研究所研究員)
8. Yu Qin*, Shuaishuai Zhang*, Shuhui Deng*, Gang An, Xiaoqi Qin, Fei Li,Yan Xu, Mu Hao, Yijun Yang , Wen Zhou# (co-correpondence), Hong Chang# , Lugui Qiu#. Epigenetic silencing 1 of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple ...
- 麥海強(中山大學腫瘤防治中心鼻咽科主任)
14. Mai HQ, Zeng ZY, Feng KT, Ye YL, Zhang CQ, Liang WJ, Guo X, Mo HY, Hong MH. Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma.Cancer Sci. 97(12):1388-1395, 2006 15. Luo DH, Chen QY, Liu H, Xu LH, Zhang HZ, Zhang L, Tang LQ, Mo HY...
- 互補試驗
.TherewassignificantcorrelationbetweentheexpressionofERCC1andtheefficacyofchemotherapy(P=0.025).TheERCC1wasanindependentprognosticfactorofcolorectalcancerbytheCOXregressionanalysis(P=0.048).CONCLUSION:ERCC1expressionmightbeoneofthepredictionmarkersofthedrugsensitivityoftheplatinumdrugsandofprognosisincolorectalcancer....
- 母義明
70. Xie Z，Hao H，Tong C，Cheng Y，Liu J，Pang Y，Si Y，Guo Y，Zang L，Mu Y，Han W.Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.Stem Cells. 2016 Mar；34（3）：627-39....
- 周永昌(香港乳腺癌專家)
LMTK3 is implicated in endocrine resistance via multiple signaling pathways Stebbing J, Filipovic A, Lit LC, Blighe K, Grothey A, Xu Y, Miki Y, Chow LW, Coombes RC, Sasano H, Shaw JA, Giamas G. Oncogene. 2012 Aug 6. doi: 10.1038/onc.2012.343. ...[12-8-6]New therapies in ...
- 董強剛
6、Han B, Liao M, Su J, Feng J, Wang E, Dong Q. The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer. Zhanghua Jie He He Hu Xi Za Zhi（中華結核和呼吸雜誌），2002, 25:727-731 7、Fan XH, Han BH, Dong QG, Sha ...
- CELL(1974年首次發刊的《細胞》期刊)
2024年8月27日，上海大學醫學院卞月珉教授與美國哈佛大學醫學院Jonathan Abraham教授團隊合作，作為共同第一作者，在國際頂級期刊《Cell》（《細胞》）上發表題為《Viral DNA polymerase structures reveal mechanisms of antiviral drug resistance》的研究論文。2024年9月，上海交通大學醫學院腫瘤系統醫學全國重點實驗室沈...
- 鄭凌伶
Bo-Wei Han, Dan-Dan Feng, Zhi-Gang Li2, Xue-Qun Luo, Hua Zhang, Xiao-Juan Li, Xing-Ju Zhang,Ling-Ling Zheng, Cheng-Wu Zeng, Kang-Yu Lin, Peng Zhang, Ling Xu and Yue-Qin Chen. A set of miRNAs that involve in the pathways ofdrug resistance and leukemic stem-cell differentiation ...
- University Health Network
1976: Identification of P-glycoprotein as a major cause of cancer drug resistance – Dr. Victor Ling 1977: Developed a technique for Peritoneal Dialysis that made it possible on a large scale – Dr. Dimitri Oreopoulos 1978: Discovery of reversibility of brain damage from alcohol with abstinence ...
- 侯廷軍
10. Yan Guan, Huiyong Sun, Youyong Li, Peichen Pan, Dan Li, Tingjun Hou*, The competitive binding between inhibitors and substrates of HCV NS3/4A protease: a general mechanism of drug resistance, Antiviral Research, 2014, 103, 60-70.11. Lei Xu, Youyong Li, Huiyong Sun, Xuechu Zhen...
- bacilli
Conclusion class 1 integron was very universal in clinical gram negative bacilli and class 2 integron was lesser. 結論1類整合子在革蘭陰性桿菌中普遍存在，2類整合子相對較少。Drugsensit ivity test showed that the drug resistance rate was in an increasing tendency ingram-negative bacilli. 藥敏結果表明...
- 邱立朋
[8]Elucidation of cellular uptake and intracellular trafficking of heparosanpolysaccharide-based micelles in various cancer cells. Int J Biol Macromol.2019, 130:755-764.[9]Redox-responsive biocompatible nanocarriers based on novel heparosanpolysaccharides for intracellular anticancer drug delivery. Asian J...
